Homepage > Company > Media > Pharma News > 2018 > Cipla’s generic Viread approved by the FDA

Cipla’s generic Viread approved by the FDA

The Food and Drug Administration has approved Cipla’s generic Viread (tenofovir disoproxil fumarate) tablets. Cipla said it would begin shipping the drug immediately.

Картинки по запросу Tenofovir disoproxil fumarate

The drug is indicated to treat patients ages 12 years and older with HIV-1 in combination with other antiretroviral agents. Cipla’s generic Viread will be available in 300-mg dosage strength.

The product had U.S. sales of roughly $725 million for the 12 months ended November 2017, according to IQVIA data.

January 29, 2018

https://www.drugstorenews.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...